معرفی
Marie-Anne Rameix-Welti is the Head of Structure in the M3P unit at the Institut Pasteur, affiliated with UMR Paris-Saclay-Versailles St-Quentin University – INSERM U1173. She leads multiple research projects focused on the molecular mechanisms of Respiratory Syncytial Virus (RSV) multiplication, including viral factory formation, virion release, and ribonucleoprotein export.
Her research interests lie at the intersection of virology, viral pathogenesis, and host-virus interactions, with a strong emphasis on RSV biology and antiviral strategies. She investigates how RSV evades host defenses, such as BST2/Tetherin, and explores drug repurposing approaches to identify novel antivirals like lonafarnib.
Her recent publications span high-impact journals including Nature Communications, PLoS Pathogens, and The Lancet Infectious Diseases, reflecting her work’s translational and clinical relevance, especially in pediatric respiratory infections and public health interventions like nirsevimab administration.
- Principal Investigator, M3P unit, Institut Pasteur
- Research focus: RSV replication, viral factories, host restriction factors
- Active in drug discovery and epidemiological modeling
She has contributed to studies on SARS-CoV-2 immune escape and combinatorial vaccines, demonstrating a broad impact in infectious disease research. Her work involves collaborations with national and international teams, supported by grants from ANR and other research programs.
